Sesen Bio Stock Price

-0.0201 (-0.87%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sesen Bio Inc SESN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0201 -0.87% 2.2999 00:00:09
Open Price Low Price High Price Close Price Prev Close
2.30 2.20 2.32 2.30 2.32
Bid Price Ask Price Spread News
2.00 3.60 1.60 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,479 3,136,540 $ 2.26 $ 7,095,188 4,322,190 0.51 - 3.57
Last Trade Time Type Quantity Stock Price Currency
19:59:15 formt 400 $ 2.2999 USD

Sesen Bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 297.47M 129.34M 129.27M $ - $ - -1.21 -3.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sesen Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SESN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.632.632.192.385,997,108-0.3301-12.55%
1 Month3.083.572.192.725,581,730-0.7801-25.33%
3 Months1.653.571.602.697,156,5230.649939.39%
6 Months1.133.570.96342.294,932,7301.17103.53%
1 Year0.56023.570.511.963,266,8811.74310.55%
3 Years1.413.570.371.812,372,4910.889963.11%
5 Years0.56995.970.371.871,974,3911.73303.56%

Sesen Bio Description

Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody-drug conjugate therapies for the treatment of cancer-based on the company's Targeted Protein Therapeutics platform. The company's lead program, Vicinium, also known as VB4-845, is currently in a Phase 3 registration trial, the VISTA Trial, for the treatment of high-grade non-muscle invasive bladder cancer.

Your Recent History
Sesen Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.